发明名称 Beta-blocking aminopropoxy benzimidazole(s) - for treating cardiovascular disorders and hypertension
摘要 <p>Benzimidazoles of formula (I) and their acid-addition salts are new:- In the formula, R' is H, alkyl or cycloalkyl; R2 is alkyl or cycloalkyl; R3 is H, primary or secondary alkyl; Y is O or S; also new are the tautomeric thiols of (I) when Y is S. 16 Cpds. are specifically claimed 4-(2-hydroxy-3-methylaminopropoxy)-2-benzimidazolinone and 1-t-butylamino-3-(2-mercapto-7-methyl-4-benzimidazolyloxy)-2-prop- anol. (I) are beta-blockers with low intrinsic stimulating activity for treating cardiovascular disorders, also having antihypertensive activity. Daily adult dose 5-100 mg. A typical cpd., 4-(3-t-butylamino-2-hydroxypropoxy)-2-benzimidazolinone hydrochloride, was prepd. in 56.3% yield by hydrogenation of 1-t-butylamino-3-(2,3-dinitrophenoxy)-2-propanol and treating the diamino prod. with phosgene.</p>
申请公布号 FR2399414(A1) 申请公布日期 1979.03.02
申请号 FR19780012492 申请日期 1978.04.27
申请人 HOFFMANN LA ROCHE ET CIE SA 发明人 ROGER EDWARD MARKWELL
分类号 A61K31/425;A61P25/02;C07D235/26;C07D235/28;C07D303/22;(IPC1-7):07D235/26;61K31/415;07D235/28 主分类号 A61K31/425
代理机构 代理人
主权项
地址